RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic ...

After years of worsening symptoms, John found answers and lifesaving, specialized aortic care through U of U Health’s ...

RapidAI announced FDA clearance of Aortic Management, part of the company’s Rapid Aortic product, a clinical artificial ...

With many more potential years of life left compared with their older counterparts, patients younger than 65 present challenges when it comes to the management of severe aortic valve disease, a review ...

More than two decades’ worth of data from a large Japanese registry are shedding light on the factors that up the odds a person will die from aortic disease—most salient are heavy smoking, higher ...

The endothelium lining the valve plays a critical role. It’s very important whether the valve consists of two or three leaflets. There is currently no way to stop calcification of the aortic valve. If ...

Aortic valve disease encompasses a spectrum of disorders affecting the aortic valve, with calcification being a hallmark of the most severe forms. Calcific aortic valve disease (CAVD) is characterised ...

The American College of Cardiology (ACC) and the American Heart Association (AHA) have published an updated guideline on the diagnosis and management of aortic disease, focusing on surgical ...

Terumo Aortic announced enrollment of the first patient in the fenestrated TREO pivotal trial in the United States. Accordi ...

Valvular heart disease, sometimes called heart valve disease, is when one or more of your heart valves don't work properly.

ViTAA’s FDA clearance on its AiORTA tool represents the first part of its planned full-suite aortic care platform.